"Biological Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenously-synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.
| Descriptor ID |
D001685
|
| MeSH Number(s) |
D23
|
| Concept/Terms |
Biological Factors- Biological Factors
- Factor, Biological
- Factors, Biological
- Biologic Agents
- Agents, Biologic
- Biologic Factors
- Factors, Biologic
- Factor, Biologic
- Biologic Factor
- Biological Agents
- Agents, Biological
- Biological Factor
|
Below are MeSH descriptors whose meaning is more general than "Biological Factors".
Below are MeSH descriptors whose meaning is more specific than "Biological Factors".
This graph shows the total number of publications written about "Biological Factors" by people in this website by year, and whether "Biological Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biological Factors" by people in Profiles.
-
Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis. Inflamm Bowel Dis. 2023 05 02; 29(5):695-704.
-
Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 08; 17(9):1718-1723.
-
Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study. Dermatol Ther. 2017 Sep; 30(5).
-
Optimizing pharmacologic management of inflammatory bowel disease. Expert Rev Clin Pharmacol. 2017 Jun; 10(6):595-607.
-
Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. J Am Soc Nephrol. 2017 Mar; 28(3):876-887.
-
Currently Used Biologic Agents in the Management of Behcet's Syndrome. Curr Med Chem. 2015; 22(16):1976-85.
-
A 2014 update on the management of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2014 Oct; 44(2):e1-2.
-
Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc Natl Acad Sci U S A. 2009 Apr 14; 106(15):6321-6.
-
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology. 2007 Jul; 133(1):312-39.
-
Social chemosignals from breastfeeding women increase sexual motivation. Horm Behav. 2004 Sep; 46(3):362-70.